Acasă Medicină-Vaccin OMS (Organizația Mondială a Sănătății) recomandă intensificarea campaniei de vaccinare antigripală (Corespondență...

OMS (Organizația Mondială a Sănătății) recomandă intensificarea campaniei de vaccinare antigripală (Corespondență de la Sanofi România)

De către

Editorial Board of J-B (Journal of Bucharest)

5 noiembrie 2022

260

Referințe

⃰ WHO surveillance update 420 (30/5/22

¹ Warren-Gash C, et al. Eur respir J. 2018 Mar 29;51(3):1701794
² Andrew MK et al. J Am Geriatr Soc. 2021 Mar;69(3):696-703
³ Samson et al. J Diabetes Sci Technol. 2019 Nov 20:1932296819883340
⁴ Kubale J, et al. Clin Infect Dis. 2021 Dec 6;73(11):e4288-e4295
⁵ Sanofi, Global Influenza Corporate Narrative. (2020). Data on file; Preaud E., Durand L., Macabeo B., Farkas N., Sloesen B., Palache A., Shupo F., Samson S.I., & Vaccines Europe influenza working group. (2014). Annual public health and economic benefits of seasonal influenza vaccination: a European estimate. BMC public health, 14, 813.
⁶ Sanofi, Global Efluelda Fluzone HD Payer Value Proposition. February 2022. Data on file; Garg, S., Jain, S., Dawood, FS., Jhung M., Pérez A., et al. (2015). Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008. Garg, Shikha et al. „Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008.” BMC infectious diseases. 15: 369.
⁷ Sanofi, Global Efluelda Fluzone HD Payer Value Proposition. February 2022. Data on file; Wootton, DG., Dickinson, L., Pertinez, H., Court, J., Eneje, O., Keogan, L., Macfarlane, L., Wilks, S., Gallagher, J., Woodhead, M., Gordon, SB. and Diggle, PJ. (2017). A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. The European Respiratory Journal, 49(6).
⁸ Sanofi, Global Efluelda Fluzone HD Payer Value Proposition. February 2022. Data on file; El Solh, AA., Aquilina, AT., Gunen, H. & Ramadan, F. (2004). Radiographic Resolution of Community-Acquired Bacterial Pneumonia in the Elderly. Journal of the American Geriatrics Society, 52(2), pp.224–229.
⁹ Sanofi, Global Influenza Corporate Narrative. (2020). Data on file; Baguelin, M., Camacho, A., Flasche, S., Edmunds, W.J. (2015). Extending the elderly- and risk- group programme of vaccination against seasonal influenza in England and Wales; a cost-effectiveness study. BMC Med. 13: 236.
¹⁰ Sanofi, Global Influenza Corporate Narrative. (2020). Data on file; World Health Organization (WHO). (2019a). Global influenza strategy 2019-2030.
¹¹ Neville S and Bruce-Lockhart (2022). Health experts brace for flu surge after Covid curbs supress infections. Financial Times, 13 February 2022.
¹² Sanofi, Global Influenza Corporate Narrative. (2020). Data on file; MacIntyre C. R., Mahimbo A., Moa A. M., & Barnes M. (2016). Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart, 102(24), 1953-1956.
¹³ Sanofi, Global Influenza Corporate Narrative. (2020). Data on file ; Mertz, D., Kim, T.H., Johnstone, J., Lam, P.P., Science, M., Kuster, S.P., Fadel, S.A., Tran, D., Fernandez, E., Bhatnagar, N., & Loeb, M. (2013). Populations at risk for severe or complicated influenza illness: systematic review and meta- analysis. BMJ. Aug 2013; 347: f5061.
¹⁴ Sanofi, Global Influenza Corporate Narrative. (2020). Data on file; Andrew M.K., MacDonald S., Ye L., Ambrose A., Boivin G., Diaz-Mitoma F., et al. (2016) Impact of frailty on influenza vaccine effectiveness and clinical outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season Canadian Immunization Conference, Ottowa, Ontario, Canada,
¹⁵ McElhaney JE., Verschoor CP., Andrew MK., et al. (2020). The immune response to influenza in older humans: beyond immune senescence. Immunity and Ageing, 17(10).